Beta emitters rhenium‐188 and lutetium‐177 are equally effective in radioimmunotherapy of HPV‐positive experimental cervical cancer

Cervical cancer caused by the infection with the human papillomavirus (HPV) remains the fourth leading killer of women worldwide. Therefore, more efficacious treatments are needed. We are developing radioimmunotherapy (RIT) of HPV‐positive cervical cancers by targeting E6 and E7 viral oncoproteins e...

Descripción completa

Detalles Bibliográficos
Autores principales: Phaeton, Rebecca, Jiang, Zewei, Revskaya, Ekaterina, Fisher, Darrell R., Goldberg, Gary L., Dadachova, Ekaterina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2015
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4708900/
https://www.ncbi.nlm.nih.gov/pubmed/26625938
http://dx.doi.org/10.1002/cam4.562

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4708900/
https://www.ncbi.nlm.nih.gov/pubmed/26625938
http://dx.doi.org/10.1002/cam4.562

Ejemplares similares